TherapeuticsMD Inc (TXMD)

Sector:
ENERGY
Industry:
OIL & GAS PRODUCTION
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Robert G. Finizio
Employees:
241
6800 BROKEN SOUND PARKWAY NW, THIRD FLOOR, BOCA RATON, FL 33487
561-961-1911

TherapeuticsMD, Inc. is a healthcare company, which focuses on developing and commercializing products for women. Its technology, SYMBODA, develops advanced hormone therapy pharmaceutical products to enable delivery of bio-identical hormones through a variety of dosage forms and administration routes. The company also manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins under the vitaMedMD and BocaGreenMD brands. TherapeuticsMD was founded by Robert G. Finizio and Brian A. Bernick in 2008 and is headquartered in Boca Raton, FL.

Data derived from most recent annual or quarterly report
Market Cap 195.804 Million Shares Outstanding423.817 Million Avg 30-day Volume 5.97 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.11
Price to Revenue7.2337 Debt to Equity-1.9169 EBITDA-148.62 Million
Price to Book Value0.0 Operating Margin-239.7646 Enterprise Value626.481 Million
Current Ratio2.168 EPS Growth0.069 Quick Ratio1.905
1 Yr BETA 1.3118 52-week High/Low 2.75 / 0.44 Profit Margin-282.9007
Operating Cash Flow Growth3.7582 Altman Z-Score-7.8555 Free Cash Flow to Firm -98.83 Million
View SEC Filings from TXMD instead.

View recent insider trading info

Funds Holding TXMD (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TXMD BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

1 Million total shares from 1 transactions

Open Market Sells (S)

29.8 Thousand total shares from 1 transactions

Exercise Derivative Conversion (M)

115 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DONEGAN MICHAEL C CAO AND VP OF FINANCE

  • Officer
214,368 2021-11-30 4

COLLINS COOPER C.

  • Director
2,236,864 2021-11-18 4

GLICKMAN MARK A CHIEF BUSINESS OFFICER

  • Officer
0 2021-10-15 2

WALKER MARLAN D GENERAL COUNSEL

  • Officer
57,797 2021-09-29 3

O'DOWD HUGH PRESIDENT

  • Officer
5,500,000 2021-08-31 2

LING KAREN

  • Director
130,309 2021-08-17 3

BISARO PAUL

  • Director
196,864 2021-08-16 3

THOMPSON TOMMY G

  • Director
865,452 2021-08-13 4

CARROLL J MARTIN

  • Director
106,864 2021-08-10 2

NAUGHTON GAIL K

  • Director
0 2021-08-10 2

MUSING JULES A.

  • Director
101,864 2021-08-10 2

RUSSELL ANGUS C.

  • Director
190,364 2021-08-10 2

DARECCA JAMES CHIEF FINANCIAL OFFICER

  • Officer
775,330 2021-08-10 2

BORKOWSKI EDWARD EVP, OPERATIONS

  • Officer
560,000 2021-07-01 2

FINIZIO ROBERT G CEO

  • Officer
  • Director
2,240,000 2021-07-01 3

MILLIGAN JOHN C.K. IV SECRETARY/CEO OF SUBSIDIARY

  • Officer
5,335,076 2021-05-10 2

CARTWRIGHT DANIEL A CHIEF FINANCIAL OFFICER

  • Officer
0 2020-03-30 0

KRASSAN MITCHELL CHIEF STRATEGY OFFICER

  • Officer
0 2020-03-30 0

BERNICK BRIAN

  • Director
6,658,371 2019-10-25 0

BARLOW JANE F

  • Director
3,144 2019-08-12 0

LAPENTA ROBERT V JR

  • Director
0 2019-06-20 0

SEGAL NICHOLAS

  • Director
0 2019-06-20 0

HOWES JEFFREY D

  • NONE
No longer subject to file 2011-10-04 0

CAMBRIDGE ROBERT

  • NONE
No longer subject to file 2011-02-15 0

MASTROPIETRO DONALD R

  • NONE
No longer subject to file 2010-12-17 0

TJON ROBIN NATALIE

  • NONE
No longer subject to file 2010-12-17 0

SARUBBI KIMBERLY

  • NONE
No longer subject to file 2010-12-17 0

RICHARDSON CHARLES V

  • Director
0 2009-08-14 0

KELLEY SKY B PRESIDENT, CEO

  • Officer
  • Director
  • 10% Owner
3,423,422 2009-07-27 0

GOLDEN ANDREW E

  • Director
0 2009-07-27 0

MANDEL RICHARD H JR

  • Director
13,100 2008-06-21 0

JENSEN JULIAN D

  • Director
0 2008-06-17 0

JENSEN DEVELOPMENT CO FORMER PRESIDENT

  • Officer
  • Director
  • 10% Owner
0 2008-06-17 0

HAMILTON DAVID S

  • Director
0 2008-06-17 0

WOODHILL GREGORY PRESIDENT, SECRETARY, CFO

  • Officer
  • Director
0 2008-06-17 0

CHESTER MICHAEL

  • Director
0 2008-06-17 0

TERRACE LANE, LLC

  • 10% Owner
646,000 2008-06-17 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DONEGAN MICHAEL C - Officer CAO AND VP OF FINANCE

2021-12-02 06:30:09 -0500 2021-11-30 S 29,790 $0.54 d 99,368 direct -7.6 0.0 1 -7.6 2

DONEGAN MICHAEL C - Officer CAO AND VP OF FINANCE

2021-12-02 06:30:09 -0500 2021-11-30 M 115,000 a 129,158 direct -7.6 0.0 1 -7.6 2

DONEGAN MICHAEL C - Officer CAO AND VP OF FINANCE

2021-12-02 06:30:09 -0500 2021-11-30 M 115,000 d 115,000 direct

COLLINS COOPER C. - Director

2021-11-22 06:30:08 -0500 2021-11-18 P 1,000,000 $0.58 a 2,236,864 direct -2.1997 -16.2437 2.1997 3 -16.2437 6

GLICKMAN MARK A - Officer CHIEF BUSINESS OFFICER

2021-10-15 17:20:32 -0400 2021-10-15 A 260,000 a 260,000 direct

GLICKMAN MARK A - Officer CHIEF BUSINESS OFFICER

2021-10-15 17:20:32 -0400 2021-10-15 A 400,000 a 400,000 direct

GLICKMAN MARK A - Officer CHIEF BUSINESS OFFICER

2021-10-15 17:20:32 -0400 2021-10-15 A 260,000 a 260,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
THERAPEUTICS MD INC TXMD 2021-12-03 22:15:03 UTC -0.8966 0.9666 5100000
THERAPEUTICS MD INC TXMD 2021-12-03 21:45:03 UTC -0.8966 0.9666 5100000
THERAPEUTICS MD INC TXMD 2021-12-03 21:15:04 UTC -0.8966 0.9666 5100000
THERAPEUTICS MD INC TXMD 2021-12-03 20:45:03 UTC -0.8966 0.9666 5100000
THERAPEUTICS MD INC TXMD 2021-12-03 20:15:03 UTC -0.8966 0.9666 5100000
THERAPEUTICS MD INC TXMD 2021-12-03 19:45:03 UTC -0.8966 0.9666 5100000
THERAPEUTICS MD INC TXMD 2021-12-03 19:15:04 UTC -0.8966 0.9666 5100000
THERAPEUTICS MD INC TXMD 2021-12-03 18:45:04 UTC -0.8049 0.8749 5100000
THERAPEUTICS MD INC TXMD 2021-12-03 18:15:03 UTC -0.8049 0.8749 5100000
THERAPEUTICS MD INC TXMD 2021-12-03 17:45:03 UTC -0.8049 0.8749 5300000
THERAPEUTICS MD INC TXMD 2021-12-03 17:15:03 UTC -0.8049 0.8749 5300000
THERAPEUTICS MD INC TXMD 2021-12-03 16:45:03 UTC -0.7921 0.8621 5300000
THERAPEUTICS MD INC TXMD 2021-12-03 16:15:04 UTC -0.7921 0.8621 5300000
THERAPEUTICS MD INC TXMD 2021-12-03 15:45:03 UTC -0.7921 0.8621 5400000
THERAPEUTICS MD INC TXMD 2021-12-03 15:15:03 UTC -0.7921 0.8621 5400000
THERAPEUTICS MD INC TXMD 2021-12-03 14:45:03 UTC -0.605 0.675 5400000
THERAPEUTICS MD INC TXMD 2021-12-03 14:15:05 UTC -0.605 0.675 5400000
THERAPEUTICS MD INC TXMD 2021-12-03 13:45:03 UTC -0.605 0.675 5400000
THERAPEUTICS MD INC TXMD 2021-12-03 13:15:03 UTC -0.605 0.675 5500000
THERAPEUTICS MD INC TXMD 2021-12-03 12:45:03 UTC -0.605 0.675 5300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund TXMD -449570.0 shares, $-449570.0 2021-07-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund TXMD -60495.0 shares, $-44850.99 2021-09-30 N-PORT

Elevate your investments